Literature DB >> 33025239

Genetic diversity of Rickettsia africae isolates from Amblyomma hebraeum and blood from cattle in the Eastern Cape province of South Africa.

Alicia D Pillay1, S Mukaratirwa2,3.   

Abstract

Rickettsia africae is a re-emerging tick-borne pathogen causing African tick bite fever (ATBF) in humans. Amblyomma variegatum is the principal vector in most sub-Sahara African countries, whereas in South Africa it is A. hebraeum. Reports of high genetic heterogeneity among R. africae isolates in southern Africa have prompted the need for molecular investigations of isolates form South Africa. Therefore, this study aimed to determine the prevalence and genetic diversity of R. africae in A. hebraeum collected from cattle, grazing pasture, as well as from blood of cattle in the Eastern Cape Province of South Africa. Amblyomma hebraeum and blood from cattle were screened by PCR and the gltA, ompA, ompB, sca4, and 17kDa genes were sequenced for R. africae from samples collected from Caquba in Port St. Johns along the coastal region in the Eastern Cape province of South Africa. The overall proportion of adult A. hebraeum that were positive for the gltA and ompA genes was 0.63 (108/180). The overall proportion of nymphs positive for the gltA and ompA genes was 0.62 (23/37) and 0.22 (20/90) from cattle blood. A positive R. africae infection was inferred by analysis of 26 sequences of the ompA, gltA, ompB, 17kDa and sca4 genes. Neighbour-joining and Maximum Likelihood analysis revealed that the study isolates were closely related to R. africae isolates from South Africa deposited in GenBank, forming a clade that was separate from north, east and west African strains. This study provides new information on the epidemiology and phylogeny of R. africae isolated from A. hebraeum ticks in the Eastern Cape province of South Africa. The heterogeneity observed between R. africae isolates from South Africa deposited in GenBank and R. africae isolates from Africa retrieved from Genbank highlight the importance of differentiation and tracking of the genetic movement among R. africae isolates in southern Africa for the better characterisation of ATBF cases, especially in rural communities and travellers visiting the region.

Entities:  

Keywords:  African tick-bite fever; Amblyomma hebraeum; Rickettsia africae; Spotted fever; Travel medicine

Mesh:

Year:  2020        PMID: 33025239     DOI: 10.1007/s10493-020-00555-6

Source DB:  PubMed          Journal:  Exp Appl Acarol        ISSN: 0168-8162            Impact factor:   2.132


  2 in total

1.  Drag-sampling of free-living ixodid ticks in the Kruger National Park.

Authors:  A M Spickett; I G Horak; L E Braack; H van Ark
Journal:  Onderstepoort J Vet Res       Date:  1991-03       Impact factor: 1.792

Review 2.  The ecology of the African vectors of heartwater, with particular reference to Amblyomma hebraeum and Amblyomma variegatum.

Authors:  T N Petney; I G Horak; Y Rechav
Journal:  Onderstepoort J Vet Res       Date:  1987-09       Impact factor: 1.792

  2 in total
  4 in total

1.  Entomological risk of African tick-bite fever (Rickettsia africae infection) in Eswatini.

Authors:  Kimberly J Ledger; Hanna Innocent; Sifiso M Lukhele; Rayann Dorleans; Samantha M Wisely
Journal:  PLoS Negl Trop Dis       Date:  2022-05-16

2.  Identification and genetic diversity analysis of Rickettsia in Dermacentor nuttalli within inner Mongolia, China.

Authors:  Zheng Gui; Hao Cai; Dong-Dong Qi; Shun Zhang; Shao-Yin Fu; Jing-Feng Yu; Xiao-Yan Si; Ting Cai; Rui Mao
Journal:  Parasit Vectors       Date:  2022-08-07       Impact factor: 4.047

Review 3.  Rickettsia-Host-Tick Interactions: Knowledge Advances and Gaps.

Authors:  Hwan Keun Kim
Journal:  Infect Immun       Date:  2022-08-22       Impact factor: 3.609

4.  Knowledge, attitudes and practices on African tick bite fever of rural livestock communities living in a livestock-wildlife interface area in the Eastern Cape Province of South Africa.

Authors:  Tandiwe Katswara; Samson Mukaratirwa
Journal:  BMC Infect Dis       Date:  2021-05-28       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.